Refine by
Tissue Imaging Articles & Analysis
17 news found
Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in distal alveolar ...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, announced the launch of its new 3D Tissue Imaging Services to researchers with comprehensive solutions for 3D imaging of tissues, including 3D Immunolabeling, Tissue Removal, 3D ...
Short for wide-area transepithelial sampling with three-dimensional analysis, WATS3D utilizes enhanced tissue acquisition, 3D imaging with AI-powered analysis, and expert pathologists to reliably detect Barrett’s esophagus (BE) and esophageal dysplasia. ...
Broncholab provides physicians with reproducible CT values for pulmonary tissue for providing quantitative support for diagnosis and follow-up examination. Broncholab can be used to support physicians in the diagnosis and documentation of pulmonary tissues images (e.g. abnormalities) from CT thoracic datasets. 3D segmentation and isolation of ...
ByFluidda
This platform helps clinicians overcome the well-known limitations associated with traditional upper endoscopic methods of screening and surveillance for BE. WATS3D utilizes advanced tissue sampling, 3D imaging technology and an Artificial Intelligence neural network to more accurately and reliably identify BE and dysplasia. ...
Perimeter S-Series is a novel medical imaging system that uses Optical Coherence Tomography (OCT) to provide clinicians with cross-sectional, real-time margin visualization (1-2 mm below the surface) of an excised tissue specimen across a variety of tissue types. ...
The lipid composition varies from tissue to tissue, even within different cells of the tissue. “MALDI-Imaging is a well-known solution provided by Creative Proteomics. ...
RIVANNA, developers of imaging-based medical solutions, announced that they have received a contract from the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. ...
Prior to joining Dana-Farber in 1996, he completed his residency in internal medicine and a fellowship in hematology and oncology at Brigham and Women's Hospital, where he also served as chief medical resident. 4D Path’s Q-Plasia OncoReader is a U.S. patented, novel pan-cancer precision diagnostic and oncology platform, unveiling previously hidden data in H&E-stained ...
Ultimately, this new code will provide patients and physicians access to histotripsy as an option to treat liver tissue non-invasively and without potential complications seen with conventional therapies like bleeding, infection, or pain from surgery. HistoSonics’ non-invasive platform combines advanced imaging and proprietary software to deliver patient ...
She served as acting-CEO from 2008-2012, and chief medical officer from 2012 until its acquisition by Qiagen (Market Cap $8B) in 2019. 4D Path, which has raised $6.4 million in funding to date and been awarded a coveted FDA Breakthrough Device Designation, applies a cloud-based, quantitative approach to finding the data previously hidden in H&E biopsy and resection images ...
Just from whole slide H&E biopsy/resection images, in seconds 4D Path can identify cancer, its pan-cancer prognostically significant molecular subtypes, grades, and molecular profile with overexpression status as well as benign lesions. ...
NEW YORK— JULY 16, 2020 — Ambra Health, makers of the leading cloud-based, medical image management suite and Invenio Imaging, a leader in rapid intraoperative tissue imaging with Stimulated Raman Histology (SRH), today announced a partnership that integrates Ambra’s image management technology ...
AVB-620 has completed a Phase Ib clinical trial assessing safety, pharmacokinetics, and fluorescence properties using tissue image analysis. A Phase II clinical trial for AVB-620 in breast cancer is ongoing. ...
Using the superior imaging properties of MRI, the applicators can be positioned more precisely allowing for more accurate delivery of radiation to the tumor site while avoiding healthy surrounding organs and tissue. ...
The Quest Spectrum™ Fluorescence Imaging Platform is designed and developed for open and minimally invasive fluorescence image-guided surgery with the capability for multiple wavelengths in a single system. ...
BySurgiMab
Basilion, PhD, Associate Professor, Case Western University, and Director, NFCR Center for Molecular Imaging, will be speaking on “The Cutting Edge” of cancer imaging developments – Thursday, June 7th, 11:45 am Kevin Hrusovsky, PerkinElmer, will be providing a keynote address on “Our Crusade to ...